“Comparative Study of Olopatadine Hydrochloride 0.1% and Emedastine Difumarate 0.05% Comparing Their Clinical Efficacy and Adverse Effects in Allergic Conjunctivitis”. 2024. Medical Forum Monthly 26 (5). https://medicalforummonthly.com/index.php/mfm/article/view/2774.